Your browser doesn't support javascript.
loading
Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children.
Rautanen, Anna; Pirinen, Matti; Mills, Tara C; Rockett, Kirk A; Strange, Amy; Ndungu, Anne W; Naranbhai, Vivek; Gilchrist, James J; Bellenguez, Céline; Freeman, Colin; Band, Gavin; Bumpstead, Suzannah J; Edkins, Sarah; Giannoulatou, Eleni; Gray, Emma; Dronov, Serge; Hunt, Sarah E; Langford, Cordelia; Pearson, Richard D; Su, Zhan; Vukcevic, Damjan; Macharia, Alex W; Uyoga, Sophie; Ndila, Carolyne; Mturi, Neema; Njuguna, Patricia; Mohammed, Shebe; Berkley, James A; Mwangi, Isaiah; Mwarumba, Salim; Kitsao, Barnes S; Lowe, Brett S; Morpeth, Susan C; Khandwalla, Iqbal; Blackwell, Jenefer M; Bramon, Elvira; Brown, Matthew A; Casas, Juan P; Corvin, Aiden; Duncanson, Audrey; Jankowski, Janusz; Markus, Hugh S; Mathew, Christopher G; Palmer, Colin N A; Plomin, Robert; Sawcer, Stephen J; Trembath, Richard C; Viswanathan, Ananth C; Wood, Nicholas W; Deloukas, Panos.
Afiliación
  • Rautanen A; Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK. Electronic address: anna.rautanen@well.ox.ac.uk.
  • Pirinen M; Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK.
  • Mills TC; Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK.
  • Rockett KA; Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
  • Strange A; Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK.
  • Ndungu AW; Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK.
  • Naranbhai V; Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK.
  • Gilchrist JJ; Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK; Department of Paediatrics, University of Oxford, Oxford OX3 9DU, UK.
  • Bellenguez C; Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK.
  • Freeman C; Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK.
  • Band G; Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK.
  • Bumpstead SJ; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
  • Edkins S; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
  • Giannoulatou E; Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK.
  • Gray E; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
  • Dronov S; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
  • Hunt SE; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
  • Langford C; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
  • Pearson RD; Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK.
  • Su Z; Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK.
  • Vukcevic D; Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK.
  • Macharia AW; KEMRI-Wellcome Trust Research Programme, Kilifi 80108, Kenya.
  • Uyoga S; KEMRI-Wellcome Trust Research Programme, Kilifi 80108, Kenya.
  • Ndila C; KEMRI-Wellcome Trust Research Programme, Kilifi 80108, Kenya.
  • Mturi N; KEMRI-Wellcome Trust Research Programme, Kilifi 80108, Kenya.
  • Njuguna P; KEMRI-Wellcome Trust Research Programme, Kilifi 80108, Kenya.
  • Mohammed S; KEMRI-Wellcome Trust Research Programme, Kilifi 80108, Kenya.
  • Berkley JA; KEMRI-Wellcome Trust Research Programme, Kilifi 80108, Kenya.
  • Mwangi I; KEMRI-Wellcome Trust Research Programme, Kilifi 80108, Kenya.
  • Mwarumba S; KEMRI-Wellcome Trust Research Programme, Kilifi 80108, Kenya.
  • Kitsao BS; KEMRI-Wellcome Trust Research Programme, Kilifi 80108, Kenya.
  • Lowe BS; KEMRI-Wellcome Trust Research Programme, Kilifi 80108, Kenya.
  • Morpeth SC; KEMRI-Wellcome Trust Research Programme, Kilifi 80108, Kenya; Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 9DU, UK; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
  • Khandwalla I; KEMRI-Wellcome Trust Research Programme, Kilifi 80108, Kenya.
  • Blackwell JM; Cambridge Institute for Medical Research and Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QP, UK; Telethon Kids Institute, The University of Western Australia, Subiaco, WA 6008, Australia.
  • Bramon E; National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health at the South London and Maudsley National Health Service (NHS) Foundation Trust and Institute of Psychiatry, King's College London, Denmark Hill, London SE5 8AF, UK.
  • Brown MA; Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Princess Alexandra Hospital, Brisbane, QLD 4102, Australia.
  • Casas JP; Farr Institute of Health Informatics, University College London, London NW1 2DA, UK.
  • Corvin A; Neuropsychiatric Genetics Research Group, Institute of Molecular Medicine, Trinity College Dublin, Dublin 2, Ireland.
  • Duncanson A; Molecular and Physiological Sciences, The Wellcome Trust, London NW1 2BE, UK.
  • Jankowski J; Associate Deans Office, John Bull Building, Peninsula School of Medicine and Dentistry, Plymouth PL6 8BU, UK.
  • Markus HS; Department of Neurology, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Mathew CG; Division of Genetics and Molecular Medicine, King's College London, London SE1 9RT, UK; Sydney Brenner Institute for Molecular Bioscience, University of Witwatersrand, Johannesburg 2193, South Africa.
  • Palmer CNA; Medical Research Institute, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK.
  • Plomin R; MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, De Crespigny Park, London SE5 8AF, UK.
  • Sawcer SJ; Department of Clinical Neurosciences, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK.
  • Trembath RC; London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK.
  • Viswanathan AC; NIHR Biomedical Research Centre at Moorfields Eye Hospital NHSFT and UCL Institute of Ophthalmology, London EC1V 2PD, UK.
  • Wood NW; Department of Molecular Neuroscience, Institute of Neurology, Queen Square, London WC1N 3BG, UK.
  • Deloukas P; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
Am J Hum Genet ; 98(6): 1092-1100, 2016 Jun 02.
Article en En | MEDLINE | ID: mdl-27236921
Bacteremia (bacterial bloodstream infection) is a major cause of illness and death in sub-Saharan Africa but little is known about the role of human genetics in susceptibility. We conducted a genome-wide association study of bacteremia susceptibility in more than 5,000 Kenyan children as part of the Wellcome Trust Case Control Consortium 2 (WTCCC2). Both the blood-culture-proven bacteremia case subjects and healthy infants as controls were recruited from Kilifi, on the east coast of Kenya. Streptococcus pneumoniae is the most common cause of bacteremia in Kilifi and was thus the focus of this study. We identified an association between polymorphisms in a long intergenic non-coding RNA (lincRNA) gene (AC011288.2) and pneumococcal bacteremia and replicated the results in the same population (p combined = 1.69 × 10(-9); OR = 2.47, 95% CI = 1.84-3.31). The susceptibility allele is African specific, derived rather than ancestral, and occurs at low frequency (2.7% in control subjects and 6.4% in case subjects). Our further studies showed AC011288.2 expression only in neutrophils, a cell type that is known to play a major role in pneumococcal clearance. Identification of this novel association will further focus research on the role of lincRNAs in human infectious disease.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neumonía Neumocócica / Polimorfismo Genético / Streptococcus pneumoniae / Bacteriemia / ARN Largo no Codificante Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Child / Child, preschool / Humans / Infant / Newborn País/Región como asunto: Africa Idioma: En Revista: Am J Hum Genet Año: 2016 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neumonía Neumocócica / Polimorfismo Genético / Streptococcus pneumoniae / Bacteriemia / ARN Largo no Codificante Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Child / Child, preschool / Humans / Infant / Newborn País/Región como asunto: Africa Idioma: En Revista: Am J Hum Genet Año: 2016 Tipo del documento: Article